Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Oligodendroglioma 1Glioma 1Glioblastoma 1Astrocytoma 1

Interventions

Temozolomide 8Radiotherapy 7Radiation 3Magnetic Resonance Spectroscopy 3Biopsy 3Vincristine 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2Procarbazine 2Lomustine 2vorasidenib 1vocimagene amiretrorepvec 1trametinib 1pemigatinib 1pembrolizumab 1mirdametinib 1fluorodopa F 18 1dabrafenib 1abexinostat 1abemaciclib 1Vorinostat 1Tretinoin 1Transurethral Resection of Bladder 1Surgical Procedures, Operative 1Standard of Care 1Spinal Puncture 1Restraint, Physical 1Radiotherapy, Conformal 1Protons 1Proton Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oligodendroglioma × Outcome Assessment, Health Care × 1 year × Clear all
NCT06625047 2026-04-29

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Mayo Clinic

Phase 4 Completed
30 enrolled
CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡